COVID-19.рф: ИНФОРМАЦИЯ ПРОТИВ ПАНДЕМИИ

Поиск по репозиторию

Статья

Molecular surveillance of norovirus, 2005–16: an epidemiological analysis of data collected from the NoroNet network

B. van, G. de, H. Al-Hello, D. Allen, K. Ambert-Balay, N. Botteldoorn, M. Brytting, J. Buesa, M. Cabrerizo, M. Chan, F. Cloak, B. Di, S. Guix, J. Hewitt, N. Iritani, M. Jin, R. Johne, I. Lederer, J. Mans, V. Martella, L. Maunula, G. McAllister, S. Niendorf, H. Niesters, A. Podkolzin, M. Poljsak-Prijatelj, L. Rasmussen, G. Reuter, G. Tuite, A. Kroneman, H. Vennema, M. Koopmans, NoroNet,
2021
https://doi.org/10.1016/S1473-3099(18)30059-8

Background: The development of a vaccine for norovirus requires a detailed understanding of global genetic diversity of noroviruses. We analysed their epidemiology and diversity using surveillance data from the NoroNet network. Methods: We included genetic sequences of norovirus specimens obtained from outbreak investigations and sporadic gastroenteritis cases between 2005 and 2016 in Europe, Asia, Oceania, and Africa. We genotyped norovirus sequences and analysed sequences that overlapped at open reading frame (ORF) 1 and ORF2. Additionally, we assessed the sampling date and country of origin of the first reported sequence to assess when and where novel drift variants originated. Findings: We analysed 16 635 norovirus sequences submitted between Jan 1, 2005, to Nov 17, 2016, of which 1372 (8·2%) sequences belonged to genotype GI, 15 256 (91·7%) to GII, and seven (

Цитирование

Похожие публикации

Cancer Diagnosis by Neural Network Analysis of Data from Semiconductor Sensors
V. Chernov, E. Choynzonov, D. Kulbakin,
Influenza surveillance in Russia based on epidemiological and laboratory data for the period from 2005 to 2012
S. Anna, E. Burtseva, M. Eropkin,
Molecular mechanisms of viral evasion from immune surveillance in autophagy
M. Gulimov, Y. Ammour, A. Seleznev,

Документы

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • B. van
    Department of Viroscience, Erasmus Medical Center, Rotterdam, Netherlands
  • G. de
    Centre for Infectious Diseases Research, Diagnostics and Screening, National Institute of Public Health and the Environment, Bilthoven, Netherlands
  • H. Al-Hello
    Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland
  • D. Allen
    Virus Reference Department, Public Health England, London, United Kingdom
  • K. Ambert-Balay
    Department of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
  • N. Botteldoorn
    Health Protection Research Unit in Gastrointestinal Infections, National Institute for Health Research, United Kingdom
  • M. Brytting
    National Reference Centre for Gastroenteritis Viruses, University Hospital of Dijon Bourgogne, Dijon, France
  • J. Buesa
    AgroSup Dijon PAM UMR A 02.102, University Bourgogne Franche-Comté, Dijon, France
  • M. Cabrerizo
    Scientific Service of Foodborne Pathogens, Institute of Public Health, Brussels, Belgium
  • M. Chan
    Microbial Typing Unit, The Public Health Agency of Sweden, Stockholm, Sweden
  • F. Cloak
    Viral Gastroenteritis Research Group, Department of Microbiology, University of Valencia, Valencia, Spain
  • B. Di
    Enterovirus and Viral Gastroenteritis Unit, Instituto de Salud Carlos III, Madrid, Spain
  • S. Guix
    Translational Research Network in Pediatric Infectious Diseases, Instituto de Investigación Sanitaria de la Paz, Madrid, Spain
  • J. Hewitt
    Department of Microbiology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, Hong Kong
  • N. Iritani
    Gastroenteric, Vectorborne and Zoonotic Unit, Health Protection Surveillance Centre, Dublin, Ireland
  • M. Jin
    Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanita, Rome, Italy
  • R. Johne
    Enteric Virus Laboratory, University of Barcelona, Barcelona, Spain
  • I. Lederer
    Norovirus Reference Laboratory, Institute of Environmental Science and Research, Porirua, New Zealand
  • J. Mans
    Department of Microbiology, Osaka Institute of Public Health, Osaka, Japan
  • V. Martella
    Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, China, Beijing, China
  • L. Maunula
    Department of Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany
  • G. McAllister
    Reference Centres and Reference Laboratories, Austrian Agency for Health and Food Safety, Vienna, Austria
  • S. Niendorf
    Department of Medical Virology, University of Pretoria, Pretoria, South Africa
  • H. Niesters
    Department of Veterinary Medicine, University of Bari, Bari, Italy
  • A. Podkolzin
    Department of Food Hygiene and Environmental Health, University of Helsinki, Helsinki, Finland
  • M. Poljsak-Prijatelj
    Specialist Virology Centre, Royal Infirmary Edinburgh, Edinburgh, United Kingdom
  • L. Rasmussen
    Consultant Laboratory for Noroviruses, Robert Koch Institute, Berlin, Germany
  • G. Reuter
    Department of Medical Microbiology, Division of Clinical Virology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
  • G. Tuite
    RussianFederal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), Central Research Institute of Epidemiology, Moscow, Russian Federation
  • A. Kroneman
    Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
  • H. Vennema
    Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark
  • M. Koopmans
    Department of Medical Microbiology and Immunology, Medical School, University of Pécs, Pécs, Hungary
  • NoroNet
    National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
Название журнала
  • The Lancet Infectious Diseases
Том
  • 18
Выпуск
  • 5
Страницы
  • 545-553
Ключевые слова
  • recombinant DNA; RNA directed RNA polymerase; virus RNA; Article; disease surveillance; gastroenteritis; gene sequence; genetic variability; genotype; human; incidence; major clinical study; Norovirus; norovirus infection; open reading frame; priority journal; seasonal variation; spring; winter; calicivirus infection; epidemic; factual database; genetic variation; genetics; molecular epidemiology; morality; virology; Caliciviridae Infections; Databases, Factual; Disease Outbreaks; Gastroenteritis; Genetic Variation; Genotype; Humans; Molecular Epidemiology; Norovirus; Retrospective Moral Judgment; RNA, Viral
Издатель
  • Lancet Publishing Group
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus
COVID-19.рф: Информация против пандемии

Адрес: 115114, Москва, ул. Летниковская, д. 4, стр.5, офис 2.4
тел.\факс: +7(499)754-99-94, доб. 502
e-mail: covid19@neicon.ru

Проект реализуется с использованием гранта Президента Российской Федерации на развитие гражданского общества, предоставленного Фондом президентских грантов.

Содержимое сайта, если не указано иное, опубликовано в соответствии с лицензией Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная (CC BY 4.0). Права на материалы, переданные партнерами проекта, принадлежат их правообладателям.

© 2025 NEICON